Cardiovascular Therapeutics

Cover image for Vol. 34 Issue 3

Edited By: Chim C. Lang, MD and Stuart D. Katz, MD

Impact Factor: 2.243

ISI Journal Citation Reports © Ranking: 2015: 60/124 (Cardiac & Cardiovascular Systems); 132/253 (Pharmacology & Pharmacy)

Online ISSN: 1755-5922


Aims and Scope

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.

Cardiovascular Therapeutics is an online journal. Online-only publication is the quickest route to publication and your accepted article will appear in an e-only published issue in a fully indexed and fully citable form.

For informal and rapid pre-submission guidance, send your abstract and brief note explaining why your manuscript is suitable by email to Julia Ballard, Journal Publishing Manager. 


Cardiovascular, Drug, Reviews, cardiology, pharmacology, pharmacokinetics, toxicology, clinical trials, therapy, pharmacy

Abstracting and Indexing Information

  • Academic Search (EBSCO Publishing)
  • Academic Search Alumni Edition (EBSCO Publishing)
  • Biological Abstracts (Thomson Reuters)
  • BIOSIS (Thomson Reuters)
  • BIOSIS Previews (Thomson Reuters)
  • CAS: Chemical Abstracts Service (ACS)
  • Current Contents: Clinical Medicine (Thomson Reuters)
  • Embase (Elsevier)
  • International Pharmaceutical Abstracts (Thomson Reuters)
  • Journal Citation Reports/Science Edition (Thomson Reuters)
  • MEDLINE/PubMed (NLM)
  • Science Citation Index (Thomson Reuters)
  • Science Citation Index Expanded (Thomson Reuters)
  • SCOPUS (Elsevier)